Postępy w Kardiologii Interwencyjnej

Full text

3/2026 vol. 22
Short communication

Image-guided decision-making in contemporary carotid revascularization

Kseniya Bankrashkova 1
,
Lukasz Tekieli 2, 3
,
R. Pawel Banys 4, 5
,
Jakub Chmiel 1, 3
,
Martyna Sikorska 1
,
Joanna Szachowicz-Jaworska 5
,
Anna Kablak-Ziembicka 1
,
Piotr Musialek 1, 3

  1. Department of Cardiac and Vascular Diseases, Jagiellonian University, Krakow, Poland

  2. Department of Interventional Cardiology, Jagiellonian University Krakow, Poland

  3. Cardiovascular Catheterization Laboratory, St. John Paul II Hospital, Krakow, Poland

  4. AGH University of Science and Technology, Krakow, Poland

  5. Department of Radiology and Imaging Diagnostics, St. John Paul II Hospital, Krakow, Poland

Adv Interv Cardiol 2026; 22, 3 (85): 524–531

DOI: https://doi.org/10.5114/aic.2026.165166
Data publikacji online: 2026/09/30
Article file
Image-guided decision.pdf
  1. Musialek P, Bonati LH, Bulbulia R, et al. Stroke risk management in carotid atherosclerotic disease: a clinical consensus statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases. Cardiovasc Res 2025; 121: 13-43.
  2. Brott TG, Howard G, Lal BK, et al. CREST-2 Investigators. Medical management and revascularization for asymptomatic carotid stenosis. N Engl J Med 2026; 394: 219-31.
  3. Tekieli L, Dzierwa K, Grunwald IQ, et al. Outcomes in acute carotid-related stroke eligible for mechanical reperfusion: SAFEGUARD-STROKE Registry. J Cardiovasc Surg 2024; 65: 231-48.
  4. Musialek P, Rosenfield K, Siddiqui AH, Grunwald IQ. Carotid stenosis and stroke: medicines, stents, surgery – “wait-and-see” or protect? Thromb Haemost 2024; 124: 815-27.
  5. Metzger DC, Soukas P, Siddiqui A, et al.; C-GUARDIANS Investigators. Safety and efficacy of a novel micro net carotid stent system: results of the C-GUARDIANS Trial. JACC Cardiovasc Interv 2025; 18: 3087-97.
  6. Musialek P, Tracz W, Tekieli L, et al. Multimarker approach in discriminating patients with symptomatic and asymptomatic atherosclerotic carotid artery stenosis. J Clin Neurol 2013; 9: 165-75.
  7. Karpenko A, Bugurov S, Ignatenko P, et al. Randomized controlled trial of conventional versus micronet-covered stent in carotid artery revascularization. JACC Cardiovasc Interv 2021; 14: 2377-87.
  8. Succar B, Zhou W. Does carotid intervention improve cognitive function? Adv Surg 2023; 57: 267-77.
  9. Musialek P, Malinowski K, Tekieli L, et al. CREST-2 findings are unchanged using an aggregated control group for the CAS and CEA trial. Adv Interv Cardiol 2026; 22: 178-89.
  10. Furie KL, Kelly PJ. Secondary prevention after ischemic stroke. N Engl J Med 2026; 394: 784-92.
  11. Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol 2004; 43: 1596-601.
  12. Russell DA, Gough MJ. Intracerebral haemorrhage following carotid endarterectomy. Eur J Vasc Endovasc Surg 2004; 28: 115-23.
  13. Galyfos G, Sianou A, Filis K. Cerebral hyperperfusion syndrome and intracranial hemorrhage after carotid endarterectomy or carotid stenting: a meta-analysis. J Neurol Sci 2017; 381: 74-82.
  14. Lin T, Lai Z, Zuo Z, et al. ASL perfusion features and type of circle of Willis as imaging markers for cerebral hyperperfusion after carotid revascularization: a preliminary study. Eur Radiol 2019; 29: 2651-8.
  15. Zimmermann A, Knappich C, Tsantilas P, et al. Different perioperative antiplatelet therapies for patients treated with carotid endarterectomy in routine practice. J Vasc Surg 2018; 68: 1753-63.
  16. Kamtchum-Tatuene J, Noubiap JJ, Wilman AH, et al. Prevalence of high-risk plaques and risk of stroke in patients with asymptomatic carotid stenosis: a meta-analysis. JAMA Neurol 2020; 77: 1524-35.
  17. Musiałek P, Tekieli L, Podlasek A. Carotid plaque characteristics and stroke risks: more questions – or more answers? Pol Heart J 2025; 83: 257-9.
  18. Pisu F, Williamson BJ, Nardi V, et al. Machine learning detects symptomatic plaques in patients with carotid atherosclerosis on CT angiography. Circ Cardiovasc Imaging 2024; 17: e016274.
  19. Zhu G, Hom J, Li Y, et al. Carotid plaque imaging and the risk of atherosclerotic cardiovascular disease. Cardiovasc Diagn Ther 2020; 10: 1048-67.
  20. Saba L, Chen H, Cau R, et al. Impact analysis of different CT configurations of carotid artery plaque calcifications on cerebrovascular events. AJNR Am J Neuroradiol 2022; 43: 272-9.
  21. Seiler A, Kammerer S, Gühl A, et al. Revascularization of high-grade carotid stenosis restores global cerebral energy metabolism. Stroke 2019; 50: 1742-50.
  22. Musialek P. Proximal embolic protection with the Mo.Ma device: a “must know how” for competent carotid artery stenting. Endovascular Today 2024; 23: 30-3.
  23. Bijuklic K, Wandler A, Hazizi F, Schofer J. The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): a prospective randomized trial. J Am Coll Cardiol 2012; 59: 1383-9.
  24. Musialek P, Grunwald IQ. Illusion of occlusion: the art of (not) protecting the brain. Eur J Vasc Endovasc Surg 2026; 71: 742-3.
  25. Wissgott C, Schmidt W, Brandt-Wunderlich C, et al. Clinical results and mechanical properties of the carotid CGUARD double-layered embolic prevention stent. J Endovasc Ther 2017; 24: 130-7.
  26. Musialek P, Mazurek A, Trystula M, et al. Novel PARADIGM in carotid revascularisation: prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard MicroNet-covered embolic prevention stent system. EuroIntervention 2016; 12: e658-70.
  27. Mazurek A, Borratynska A, Malinowski KP, et al. MicroNET-covered stents for embolic prevention in patients undergoing carotid revascularisation: twelve-month outcomes from the PARADIGM study. EuroIntervention 2020; 16: e950-2.
  28. Karpenko A, Bugurov S, Ignatenko P, et al. Randomized controlled trial of conventional versus MicroNet-covered stent in carotid artery revascularization: 12-month outcomes. JACC Cardiovasc Interv 2023; 16: 878-80.
  29. Tekieli L, Afanasjev A, Mazgaj M, et al. A multi-center study of the MicroNET-covered stent in consecutive patients with acute carotid-related stroke: SAFEGUARD-STROKE. Adv Interv Cardiol 2024; 20: 172-93.
  30. Karpenko A, Castrucci T, Partyka L, et al. Cerebral embolism in transfemoral carotid artery stenting using proximal protection and micronet-covered stents: PROXGUARD Study. JACC Cardiovasc Interv 2026 (in press).
  31. Grafmuller LE, Lehane DJ, Dohring CL, et al. Impact of calcified plaque volume on technical and 3-year outcomes after transcarotid artery revascularization. J Vasc Surg 2023; 78: 150-7.
  32. Sangiorgi G, Bedogni F, Sganzerla P, et al. The Virtual histology In CaroTids Observational RegistrY (VICTORY) study: a European prospective registry to assess the feasibility and safety of intravascular ultrasound and virtual histology during carotid interventions. Int J Cardiol 2013; 168: 2089-93.
  33. Timaran CH, Rosero EB, Martinez AE, et al. Atherosclerotic plaque composition assessed by virtual histology intravascular ultrasound and cerebral embolization after carotid stenting. J Vasc Surg 2010; 52: 1188-94.
  34. Schofer J, Musiałek P, Bijuklic K, et al. A prospective, multicenter study of a novel mesh-covered carotid stent: the CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). JACC Cardiovasc Interv 2015; 8: 1229-34.
  35. Sabat J, Bock D, Hsu CH, et al. Risk factors associated with microembolization after carotid intervention. J Vasc Surg 2020; 71: 1572-8.
  36. Musialek P, Tekieli L, Umemoto T. Carotid antiembolic (“Mesh”) stents: not created equal. J Soc Cardiovasc Angiogr Interv 2024; 3: 102429.
  37. Mazurek A, Malinowski K, Rosenfield K, et al.; CARMEN (CArotid Revascularization Systematic Reviews and MEta-aNalyses) Investigators. Clinical outcomes of second- versus first-generation carotid stents: a systematic review and meta-analysis. J Clin Med 2022; 11: 4819.
  38. Mazurek A, Malinowski K, Sirignano P, et al. (CArotid Revascularization systematic reviews and MEta-aNalyses CARMEN Collaborators). Carotid artery revascularization using second generation stents versus surgery: a meta-analysis of clinical outcomes. J Cardiovasc Surg 2023; 64: 570-82.
  39. Musialek P, Mazurek A, Kolvenbach R, et al. 5-year clinical and ultrasound outcomes in CARENET prospective multicenter trial of CGuard MicroNET-covered carotid stent. JACC Cardiovasc Interv 2022; 15: 1889-91.
  40. Rantner B, Bellmunt-Montoya S. Beyond successful carotid interventions: a broader assessment for long term results in asymptomatic patients. Eur J Vasc Endovasc Surg 2024; 67: 538-9.
  41. Pieniazek P, Musialek P, Kablak-Ziembicka A, et al. Carotid artery stenting with patient- and lesion-tailored selection of the neuroprotection system and stent type: early and 5-year results from a prospective academic registry of 535 consecutive procedures (TARGET-CAS). J Endovasc Ther 2008; 15: 249-62.
  42. Trystula M, Van Herzeele I, Kolvenbach R, et al. Next-generation transcarotid artery revascularization: TransCarotid flOw Reversal Cerebral Protection And CGUARD MicroNET-Covered embolic prevention stent system to reduce strokes – TOPGUARD Study. J Cardiovasc Surg 2024; 65: 181-94.
  43. Podlasek A, Grunwald IQ, Musiałek P. The evolution from an “average” study patient to patient-specific characteristics to guide interventions in vascular medicine. Pol Arch Intern Med 2021; 131: 5-8.
  44. Musialek P, Grunwald IQ, Siddiqui AH. ESC consensus statement on stroke risk management in carotid atherosclerotic disease: 10 key points. Eur Heart J 2025; 4: 4150-3.
  45. Abbott JD, Amoroso N, Aronow H, et al. Clinical conference proceedings: International Andreas Gruentzig Society (IAGS) 2026 summary document. J Invasive Cardiol 2026; 38: 8.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications